Event Brief
AstraZeneca stock drops 9% after heart drug trial
Filed: Jul 09, 2026 at 6:00 AM ET
Summary: AstraZeneca shares fell about 9% after a late-stage heart drug trial missed its primary target.
WHO: AstraZeneca
WHAT: A late-stage heart drug trial missed its primary endpoint, prompting a sharp stock drop
WHEN: Jul 09, 2026 at 4:53 AM ET
WHERE: United Kingdom
WHY: Cause not yet established.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →